Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effects on emotion recognition and response inhibition
NCT02350946Phase 2Unknown
- Sponsor
- RWTH Aachen University
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin (2 arms), sponsored by RWTH Aachen University. Primary endpoints: BOLD response during emotion recognition in contrast with a corresponding control condition at Day 14 and BOLD response during response inhibition (Emotional Go/ Nogo) in contrast with a corresponding control condition at Day 14. Status: unknown.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NCT02350946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350946.